Genetic errors linked to aging underlie leukemia that develops after cancer treatment
New research by Daniel Link, MD, and colleagues at The Genome Institute at Washington University has revealed that mutations that accumulate randomly as a person ages can play a role in a fatal form of leukemia that develops after treatment for another cancer.
Some aggressive cancers may respond to anti-inflammatory drugs
New research from the School of Medicine raises the prospect that some cancer
patients with aggressive tumors may benefit from a class of anti-inflammatory drugs currently in use against rheumatoid arthritis.